Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients with Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Stroke 49:2237-2240, Jin, C.,et al, 2018
Treatment and Outcome of Hemorrhagic Transformation after Intravenous Alteplase in Acute Ischemic Stroke
Stroke 48:e343-e361, Yaghi, S.,et al, 2017
A 76-Year-Old Man with Acute-Onset Left-Sided Weakness and Numbness
Neurol 86:e156-e160, Renthal, W.,et al, 2016
Unexplained Early Neurological Deterioration After Intravenous Thrombolysis
Stroke 45:2004-2009, Seners, P.,et al, 2014
Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013
Thrombolysis for Ischemic Stroke Associated with Infective Endocarditis
Stroke 44:2917-2919, Asaithambi, G.,et al, 2013
Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset
Stroke 41:288-294, Diedler,J.,et al, 2010
Management of Thrombolysis-Associated Symptomatic Intracerebral Hemorrhage
Arch Neurol 67:965-969, Goldstein,J.N., et al, 2010
Established Treatments for Acute Ischaemic Stroke
Lancet 369:319-330, Khaja,A.M. &Grotta,J.C., 2007
Response of Intra-Arterial and Combined Intravenous and Intra-Arterial Thrombolytic Therapy in Patients with Distal Internal Carotid Artery Occlusion
Stroke 33:1821-1826,1827, Zaidat,O.O,et al, 2002
Arterial Reocclusion in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
Neurol 59:862-867, Alexandrov,A.V. &Grotta,J.C., 2002
Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke
Stroke 33:2866-2870, Lisboa,R.C.,et al, 2002
Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001
Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001
Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001
Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999
Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999
Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999
The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
PROACT:Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute MCA Stroke
Stroke 29:4-11, delZoppo,G.J.,et al, 1998
I. V. t-PA for Acute Ischemic Stroke, Feasibility, Safety & Efficacy in the First Year of Clinical Practice
Stroke 29:18-22, Chiu,D.,et al, 1998
Early Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator in Vertebrobasilar Ischemic Stroke
Arch Neurol 55:466-469, 4501998., Grond,M.,et al, 1998
Randomised Double-Blind Placebo-Controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II)
Lancet 352:1245-1251,1238, Hacke,W.,et al, 1998
Alteplase Not Yet Proven for Acute Ischaemic Stroke
Lancet 352:1238-1239,1245, Bath,P., 1998
Brain SPECT with HMPAO & Safety of Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 28:1830-1834, Alexandrov,A.V.,et al, 1997
Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2109-21181997., , 1997
Should Thrombolytic Therapy be the First-Line Treatment for Acute Ischemic Stroke
NEJM 337:1309-1313, Caplan,L.R.,et al, 1997
Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996
Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996
Streptokinase for Acute Ischemic Stroke with Relationship to Time of Administration
JAMA 276:961-966, 9951996., Donnan,G.A.,et al, 1996
Tissue Plasminogen Activator for Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NEJM 333:1581-1587, 12,1995., 1995
Randomised Contr Trial of Streptokinase
Aspirin & Comb in Trtm of Acute Ischaemic Stroke, Multictr Acute Stroke Trial-Italy, Lancet 346:1509, 15145,1504,1995., 1995
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992
Urgent Therapy for Stroke Part I, Pilot Study of Tissue Plasminogen Activator Administered within 90 Minutes
Stroke 23:632-640, Brott,T.G.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
Thrombolysis in Acute Ischemic Stroke:Does it Work
Stroke 23:1826-1839, Wardlaw,J.M.&Warlow,C.P., 1992
Intracarotid Urokinase with Thromboembolic Occlusion of the Middle Cerebral Artery
Stroke 19:802-812, Mori,E.,et al, 1988
Fatal Ischaemic Brain Oedema after Early Thrombolysis with Tissue Plasminogen Activator in Acute Stroke
BMJ 297:1571-1574, Koudstaal,P.J.,et al, 1988
Thrombolysis & Stroke, Past & Future
Arch Neurol 44:748-768, Sloan,M.A., 1987
Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated with Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 48:2031-2033, Tsivgoulis, G. & Safouris, A., 2017
Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia
Stroke 47:1825-1830, Myslimi, F.,et al, 2016